VP1 (PF3D7_1456800) is a type I, K⁺-dependent, membrane-bound V-type H⁺-translocating pyrophosphatase of Plasmodium falciparum that couples pyrophosphate hydrolysis to proton translocation across the parasite plasma membrane (PMID:11378198). It localizes to the parasite plasma membrane and punctate intracellular inclusions, and its K⁺-stimulated, AMDP-inhibitable PPase activity is detectable in trophozoite membranes (PMID:11378198). VP1 is essential for asexual blood-stage development: conditional deletion prolongs the ring stage and completely blocks the ring-to-trophozoite transition, culminating in parasite death, and this defect is rescued by a heterologous proton-pumping pyrophosphatase from Arabidopsis thaliana but not by a non-proton-pumping soluble yeast pyrophosphatase, demonstrating that proton pumping fueled by pyrophosphate—not mere hydrolysis—is the essential function (PMID:38048362). Its role in maintaining pyrophosphate homeostasis at the plasma membrane is distinct from that of soluble cytoplasmic and organellar pyrophosphatases (PMID:40027813). VP1 has been heterologously expressed, purified, and shown to retain catalytic activity in detergent, and is selectively inhibited by pyrazolo[1,5-a]pyrimidine-based mPPase inhibitors, establishing it as tractable for structure-based drug discovery (PMID:40424284).